Graphene quantum dots as bimodal imaging agent for X-ray and Computed Tomography.

Eur J Pharm Biopharm

Brazilian Nuclear Energy Commission, Nuclear Engineering Institute, Laboratory of Nanoradiopharmacy and Synthesis of New Radiopharmaceuticals, Rio de Janeiro 21941906, RJ, Brazil; Rio de Janeiro State University, Laboratory of Radiopharmacy and Nanoradiopharmaceuticals, Rio de Janeiro 23070200, RJ, Brazil. Electronic address:

Published: October 2022

The urgency of new contrast agents, especially for X-ray and Computed Tomography (CT) is increasing each day. Although both imaging modalities are the most routinely used imaging techniques, the availability of contrast agent is very limited. In this scenario, the use of graphene quantum dots (GQDs), a member of the graphene family, which has several characteristics, including low toxicity, good biocompatibility and physical-chemical properties, may represent an important application of this material. Thus, using X-ray (conventional) and CT analysis was evaluated the applicability of GQDs as contrast agent for both imaging modalities. The results demonstrated that GQDs are able to attenuate X-ray forming sharp imaging in both modalities. The data broaden the spectrum of GQDs use.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejpb.2022.08.020DOI Listing

Publication Analysis

Top Keywords

imaging modalities
12
graphene quantum
8
quantum dots
8
x-ray computed
8
computed tomography
8
contrast agent
8
imaging
5
dots bimodal
4
bimodal imaging
4
imaging agent
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!